A novel mutation in the ALS2 gene in an iranian kurdish family with juvenile amyotrophic lateral sclerosis

Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):148-151. doi: 10.1080/21678421.2022.2100263. Epub 2022 Jul 19.

Abstract

Amyotrophic lateral sclerosis (ALS) is a rare disorder that affects both upper and lower motor neurons. Mutations in Alsin Rho Guanine Nucleotide Exchange Factor (ALS2) correlates with three similar but distinctive syndromes, including the juvenile form of ALS. An Iranian Kurdish family was involved in this study and all members were evaluated with relevant clinical guidelines. Whole exome sequencing and sanger sequencing were applied to all family members to undermine the possible genetic factors. A substitution c. 2110 C>T (p. Arg704X) identified in the ALS2 gene. Bioinformatics analysis indicated the mutation is located in the well-conserved and functional domain of the protein. This study recognized a novel mutation in the ALS2 gene in a proband with the juvenile form of ALS. To our knowledge, this is the first identified ALS2 mutation among the Iranian population.

Keywords: ALS2; Amyotrophic lateral sclerosis; bioinformatics; whole-exome sequencing.

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Guanine Nucleotide Exchange Factors / genetics
  • Humans
  • Iran
  • Motor Neurons / metabolism
  • Mutation

Substances

  • ALS2 protein, human
  • Guanine Nucleotide Exchange Factors

Supplementary concepts

  • Amyotrophic Lateral Sclerosis 2, Juvenile